Abstract
IntroductionThe prevalence and mortality of end-stage liver disease (ESLD) are increasing in the UK. Disease trajectory is unpredictable, making accurate prediction of prognosis challenging and there has been historic reluctance...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have